126 related articles for article (PubMed ID: 20840816)
1. [Research on the relationship between non-small cell lung cancer with neuroendocrine differentiation and the biological characteristics and prognosis].
Zhang J; Zheng K; Guo Y; Zhang P; Zhan Z
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):873-6. PubMed ID: 20840816
[TBL] [Abstract][Full Text] [Related]
2. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.
Slodkowska J; Zych J; Szturmowicz M; Demkow U; Rowinska-Zakrzewska E; Roszkowski-Sliz K
Int J Biol Markers; 2005; 20(4):217-26. PubMed ID: 16398403
[TBL] [Abstract][Full Text] [Related]
4. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
7. [The value of neuroendocrine markers for response to therapy and survival in patients with advanced non-small cell lung cancer].
Petrović M; Ilić N; Baskić D
Srp Arh Celok Lek; 2010; 138(1-2):37-42. PubMed ID: 20422910
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
Petrović M; Baskić D; Banković D; Ilić N
Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
[TBL] [Abstract][Full Text] [Related]
10. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuroendocrine markers in non-small cell lung cancer.
Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.
Sundaresan V; Reeve JG; Stenning S; Stewart S; Bleehen NM
Br J Cancer; 1991 Aug; 64(2):333-8. PubMed ID: 1654075
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine differentiation is not a malignant index of non-small cell lung cancer].
Dai L; Sun Y; Li X; Chen K
Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):646-52. PubMed ID: 21859545
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer.
Chang KT; Huang CY; Tsai CM; Chiu CH; Lok YY
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L438-45. PubMed ID: 15894559
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
16. [Expression of CD56, as a potential diagnostic marker, in small cell carcinoma].
Yun JP; Xiang J; Hou JH; Tian QH; Fu J
Ai Zheng; 2005 Sep; 24(9):1140-3. PubMed ID: 16159442
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases.
Sterlacci W; Fiegl M; Hilbe W; Auberger J; Mikuz G; Tzankov A
Virchows Arch; 2009 Aug; 455(2):125-32. PubMed ID: 19652998
[TBL] [Abstract][Full Text] [Related]
18. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.
Ather MH; Abbas F; Faruqui N; Israr M; Pervez S
BMC Urol; 2008 Dec; 8():21. PubMed ID: 19115997
[TBL] [Abstract][Full Text] [Related]
19. [Study on the specific expressions of p53, bcl-2 and c-myc in non-small cell lung cancer with neuroendocrine differentiation].
Zhang W; Lin Y; Xiong Y; Liu M; Chen F
Zhongguo Fei Ai Za Zhi; 2002 Feb; 5(1):21-4. PubMed ID: 21315022
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary large cell carcinoma expressing neuroendocrine markers: the morphological, biological, and neuroendocrine features of their cell lines and surgical cases.
Kasai K; Kameya T; Kawakubo Y; Sato Y; Wada C; Itoh H
Jpn J Cancer Res; 1992 Sep; 83(9):1002-10. PubMed ID: 1331003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
